Advantis Corp. Looking to Team Up For MJBIZCON

GlobeNewswire - finance.yahoo.com Posted 6 years ago

NEWPORT BEACH, CA, Oct. 30, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – ADVANTIS CORPORATION (OTC PINK: ADVT) announced that it is in negotiations to partner with two undisclosed publicly traded companies to present at next month’s Las Vegas MJBIZCON.

Advantis is making big strides toward expanding its product and distribution base during this quarter. The company has been building on its self-branded product lines, expanding on its manufacturing and marketing partnerships, and gaining access to additional product distribution pipelines. “We are laying the groundwork for the coming rapid expansion,” according to Cherry. “We are negotiating an agreement to co-present or have some other joint involvement in establishing a presence at Las Vegas MJ BIZ Con. These are organizations we are already working with to deliver some of our self-branded products; sublingual’s, CBD oils, other manufacturing support. We have found mutually beneficial ways to advance our business relationships. We’re working out the details of how jointly presenting at the conference will also be mutually beneficial.” Cherry says the companies he is looking to partner with are already expanding Advantis’ product lineup, and the company is further looking to create a synergy that will result in gaining access to an international product distribution pipeline.

“We are seizing the opportunity,” Cherry explained. “These companies have an international reach. Additional distribution channels for CBD products; the upcoming Pet Division products; they would have access to our pipeline, as well; packaging solutions -- Amster-Can. The list goes on. I really hope we team up for the conference next month. I think, together, we will make a big impact at the event.” Advantis is working toward the release of its sublingual strips, and Cherry says he hopes the timing is right for that and other products to be launched on the greater stage. “We have some additional new products we are almost set to announce,” Cherry concluded. “Our partners have a lot to do with that, so spreading our brand is of a mutual concern. I truly believe this is the beginning of a monumental relationship.”

Advantis wishes to thank Investors Hangout for mentioning the company in their podcast.

Links to Advantis pictures and websites can be found on Facebook and Instagram pages, and at advantiscorp.com, rosin6.com, elixicure.com, and amstercan.com. 

About Advantis Corporation

Advantis Corporation (ADVT) focuses on the development of innovative products that supply the medical, research, and pharmaceutical industries. The company additionally establishes partnerships with businesses that develop and sell proprietary pain management, and consumer products and services. 

Forward Looking Statements: This news release contains forward-looking statements made by ADVANTIS CORPORATION. All such statements included in this press release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Actual results may differ materially from those indicated by these statements. The following risk factors, among others, could cause actual results to differ materially from those described in any forward- looking statements. These risks and uncertainties include, but are not limited to, economic conditions, changes in the law or regulations, demand for products of the Company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements. Forward- looking statements are typically identified by the words: believe, expect, anticipate, intend, estimate, and similar expressions or which by their nature refer to future events. The Company is not entitled to rely on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 because it is not registered under either Act.